Wegovy tablets and injections are FDA-approved in adults for: weight loss and weight management in adults with obesity or adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) reducing major cardiovascular event risks (such as heart attack, stroke, or death) in adults with established CV disease and either obesity or overweight Wegovy injection is also FDA-approved for: weight loss and weight management patients with obesity who are 12 years and older non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), this is an accelerated approval
Factors such as symptoms, current medications, age, medical history, and hormone levels will be considered in determining protocols
Cell Tissue Res 377, 153159 (2019)
Other common peptide therapies are for muscle growth and injury recovery
Do not take any lipotropic injections containing phentermine if you have cardiovascular disease, hyperthyroidism, glaucoma, take monoamine oxidase inhibitors, or have a history of drug dependency
